5 Year Evolution of PCI vs CABG in Large Randomized Studies on Acute and Chronic Coronary Syndrome

Left main lesions in acute coronary syndrome (ACS) represent a major risk and, at present, the best revascularization strategy is a matter of debate. Though many studies and registries have excluded this group of patients, there is data on the pros and cons of both percutaneous coronary intervention (PCI) and cardiac artery bypass graft (CABG). 

Evolución a 5 años de la angioplastia vs cirugía en los grandes estudios sobre síndromes agudos y crónicos

This analysis looked at 4 randomized studies comparing PCI with drug eluting stents (DES) vs. CABG (SYNTAX, PRECOMBAT, NOBLE and EXCEL) including a total of 1,466 patients (33.4%) with SCA and 2,927 without SCA (NSCA).

Primary end point was all cause mortality at 5 years. Mean age was 65 and most patients were men. There were no significant differences between the groups, except for a higher prevalence of diabetes, prior MI, ejection fraction <50 and higher SYNTAX score, among SCA patients (26.4 vs. 25.2; p < 0.001).

Time from randomization to procedure was shorter in patients undergoing PCI.

At 30 days, there was higher cardiovascular and non-cardiovascular mortality in SCA patients vs. NACS (1.8 vs. 0.5 p<0.001 AND 1.9 vs. 0.5 p<0.001 respectively).

MI rate was higher in ACS patients both at one and five year followup (2.3% vs. 1.0%; HR 2.73, 95% CI ;1.63-4.58; p < 0.001 and 5.7% vs. 3.8%; HR 1.70, 95%CI: 1.25-2.31; p < 0.001, respectively).

Read also: Minimal Stent Area: New IVUS Parameter?

MI rate was higher in ACS patients both at one and five year followup (2.3% vs. 1.0%; HR 2.73, 95% CI ;1.63-4.58; p < 0.001 and 5.7% vs. 3.8%; HR 1.70, 95%CI: 1.25-2.31; p < 0.001, respectively).

Primary end point resulted similar with PCI for both ACS and NACS patients (10.9% vs 11.5% HR, 0.93; 95% CI, 0.68-1.27 and 11.3%vs 9.6% HR, 1.19; 95% CI, 0.95-1.50 respectively). There was a lower rate of stroke in the PCI group, but this group also showed higher need for repeat revascularization or MI vs. CABG patients. 

Conclusion

Among patients undergoing left main revascularization with low to intermediate coronary anatomical complexity, patients presenting ACS had a higher rate of early mortality. However, 5-year mortality was similar between PCI and CABG. In the short term, PCI had a relative advantage over CABG in terms of stroke. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes. A Pooled Analysis of 4 Randomized Clinical Trials

Reference: Prakriti Gaba, et al. JAMA Cardiol. doi:10.1001/jamacardio.2023.1177.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...